Axsome Therapeutics, Inc. (AXSM)
174.17
-2.84
(-1.60%)
USD |
NASDAQ |
Jan 15, 16:00
174.25
+0.08
(+0.05%)
After-Hours: 18:47
Axsome Therapeutics SG&A Expense (TTM): 514.57M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 401.86M |
| Gilead Sciences, Inc. | 5.886B |
| Vanda Pharmaceuticals, Inc. | 214.26M |
| Madrigal Pharmaceuticals, Inc. | 715.08M |
| Innoviva, Inc. | 112.52M |